Lyka Labs Q1 FY27 Profit Rs 2.1 Cr; Divests Subsidiary

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Lyka Labs Q1 FY27 Profit Rs 2.1 Cr; Divests Subsidiary

Lyka Labs reported a standalone net profit of Rs 2.10 crore for the quarter ended June 30, 2026, a turnaround from previous losses. The company also approved divesting its entire stake in subsidiary Lyka BDR International Ltd.

Lyka Labs Reports Profitability Turnaround and Subsidiary Divestment

Lyka Labs posted a standalone net profit of ₹2.10 crore for the quarter ending June 30, 2026. The company has also approved the divestment of its entire 100% stake in its subsidiary, Lyka BDR International Ltd.

Reader Takeaway: Profitability improves while shedding a loss-making subsidiary aids balance sheet cleanup.

What just happened

Lyka Labs Limited announced its unaudited financial results for the first quarter of the financial year 2026-27. The company reported standalone revenue from operations of ₹42.31 crore and a standalone net profit of ₹2.10 crore. On a consolidated basis, the net profit stood at ₹2.05 crore.

Additionally, the Board of Directors approved the divestment of a 100% equity stake in its subsidiary, Lyka BDR International Limited. The Audit Committee is tasked with overseeing this process.

Why this matters

The return to profitability is a significant positive signal for investors, especially after a period of losses. The strategic divestment of Lyka BDR International, which had a negative net worth of ₹4.49 crore and contributed 8% to consolidated income last fiscal, aims to streamline the company's operations and financial structure.

The backstory

Lyka Labs Limited operates in the pharmaceutical sector. The company's financial figures for previous periods have been restated following the sanction of a Scheme of Amalgamation by the NCLT, Ahmedabad Bench, on March 16, 2026. This scheme involved the merger of Lyka Export Limited with Lyka Labs Limited.

What changes now

The divestment signals a move towards portfolio optimization and a focus on core operations. The reduction of a subsidiary with a negative net worth is expected to strengthen the company's financial health and potentially improve key financial ratios.

Risks to watch

Investors will be keen to observe the successful completion of the subsidiary divestment and its impact on the company's balance sheet. The final sale price and terms will be crucial.

Peer comparison

(No specific peer comparison data was provided in the filing.)

Context metrics (time-bound)

  • Standalone Revenue (Q1 FY27): ₹42.31 crore
  • Standalone Net Profit (Q1 FY27): ₹2.10 crore
  • Consolidated Net Profit (Q1 FY27): ₹2.05 crore
  • Lyka BDR International Ltd. Net Worth (as of March 31, 2026): ₹(4.49) crore

What to track next

Investors should closely monitor the updates on the divestment of Lyka BDR International Ltd. and the company's subsequent financial performance as it focuses on its streamlined operations.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.